Tscan Therapeutics Inc
TCRX
Market Cap$319.36M
Close$
Share Statistics
| Market cap | $319.36 Million |
|---|---|
| Enterprise Value | $219.75 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-1.36 |
| Beta | 0.0 |
| Outstanding Shares | 43,628,149 |
| Avg 30 Day Volume | 214,923 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -3.58 |
|---|---|
| PEG | -75.3 |
| Price to Sales | - |
| Price to Book Ratio | 2.44 |
| Enterprise Value to Revenue | 10.44 |
| Enterprise Value to EBIT | -2.35 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.42 |
| Debt to Equity | 0.61 |
Revenue Sources
No data
ESG Score
No data
About Tscan Therapeutics Inc
61 employees